Glioblastoma is an aggressive brain cancer requiring improved treatments. Existing methods of drug discovery and development require years before new therapeutics become available to patients. Zebrafish xenograft models hold promise for prioritizing drug development. We have developed an embryo–larval zebrafish xenograft assay in which cancer cells are implanted in a brain microenvironment to discover and prioritize compounds that impact glioblastoma proliferation, migration, and invasion. We illustrate the utility of our assay by evaluating the well-studied, phosphatidylinositide 3-kinase inhibitor LY294002 and zinc oxide nanoparticles (ZnO NPs), which demonstrate selective cancer cytotoxicity in cell culture, but the in vivo effectiveness has not been established. Exposures of 3.125–6.25 μM LY294002 significantly decreased proliferation up to 34% with concentration-dependent trends. Exposure to 6.25 μM LY294002 significantly inhibited migration/invasion by ∼27% within the glioblastoma cell mass (0–80 μm) and by ∼32% in the next distance region (81–160 μm). Unexpectedly, ZnO enhanced glioblastoma proliferation by ∼19% and migration/invasion by ∼35% at the periphery of the cell mass (161+ μm); however, dissolution of these NPs make it difficult to discern whether this was a nano or ionic effect. These results demonstrate that we have a short, relevant, and sensitive zebrafish-based assay to aid glioblastoma therapeutic development.
Get full access to this article
View all access options for this article.
References
1.
HegiME, DiserensA-C, GorliaT, HamouM-F, de TriboletN, WellerM, et al.MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma. New Engl J Med, 2005; 352:997–1003.
2.
DeAngelisLM. Brain tumors. New Engl J Med, 2001; 344:114–123.
3.
Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 2008; 455:1061–1068.
4.
LalS, La DuJ, TanguayRL, GreenwoodJA. Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment. J Neurosci Res, 2012; 90:769–781.
5.
MarquesIJ, WeissFU, VleckenDH, NitscheC, BakkersJ, LagendijkAK, et al. Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer, 2009; 9:128.
6.
GeigerGA, FuW, KaoGD. Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system. Cancer Res, 2008; 68:3396–3404.
7.
StoletovK, MontelV, LesterRD, GoniasSL, KlemkeR. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci U S A, 2007; 104:17406–17411.
8.
NicoliS, RibattiD, CotelliF, PrestaM. Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res, 2007; 67:2927–2931.
9.
HaldiM, TonC, SengWL, McGrathP. Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis, 2006; 9:139–151.
10.
WebbDJ, HorwitzAF. New dimensions in cell migration. Nat Cell Biol, 2003; 5:690–692.
11.
FakoVE, FurgesonDY. Zebrafish as a correlative and predictive model for assessing biomaterial nanotoxicity. Adv Drug Deliv Rev, 2009; 61:478–486.
12.
StoletovK, KatoH, ZardouzianE, KelberJ, YangJ, ShattilS, et al. Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci, 2010; 123:2332–2341.
13.
ZonLI, PetersonRT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov, 2005; 4:35–44.
14.
LamSH, ChuaHL, GongZ, LamTJ, SinYM. Development and maturation of the immune system in zebrafish, Danio rerio: a gene expression profiling, in situ hybridization and immunological study. Dev Comp Immunol, 2004; 28:9–28.
15.
YangXJ, CuiW, GuA, XuC, YuSC, LiTT, et al. A novel zebrafish xenotransplantation model for study of glioma stem cell invasion. PLoS One, 2013; 8:e61801.
16.
LeeSL, RouhiP, Dahl JensenL, ZhangD, JiH, HauptmannG, et al. Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proc Natl Acad Sci U S A, 2009; 106:19485–19490.
17.
LeeLM, SeftorEA, BondeG, CornellRA, HendrixMJ. The fate of human malignant melanoma cells transplanted into zebrafish embryos: assessment of migration and cell division in the absence of tumor formation. Dev Dyn, 2005; 233:1560–1570.
18.
JeongJ-Y, KwonH-B, AhnJ-C, KangD, KwonS-H, ParkJA, et al. Functional and developmental analysis of the blood–brain barrier in zebrafish. Brain Res Bull, 2008; 75:619–628.
19.
JangH, LalS, GreenwoodJ. Calpain 2 is required for glioblastoma cell invasion: regulation of matrix metalloproteinase 2. Neurochem Res, 2010; 35:1796–1804.
20.
HanL, YangY, YueX, HuangK, LiuX, PuP, et al. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of beta-catenin-mediated transcription. Brain Res, 2010; 1366:9–17.
21.
SuJD, MayoLD, DonnerDB, DurdenDL. PTEN and phosphatidylinositol 3′-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Res, 2003; 63:3585–3592.
22.
JoyAM, BeaudryCE, TranNL, PonceFA, HolzDR, DemuthT, et al. Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis. J Cell Sci, 2003; 116:4409–4417.
23.
HanleyC, LayneJ, PunnooseA, ReddyKM, CoombsI, CoombsA, et al. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology, 2008; 19:295103.
24.
ReimersMJ, La DuJK, PerieraCB, GiovaniniJ, TanguayRL. Ethanol-dependent toxicity in zebrafish is partially attenuated by antioxidants. Neurotoxicol Teratol, 2006; 28:497–508.
25.
KimmelCB, BallardWW, KimmelSR, UllmannB, SchillingTF. Stages of embryonic development of the zebrafish. Dev Dyn, 1995; 203:253–310.
26.
MandrellD, TruongL, JephsonC, SarkerMR, MooreA, LangC, et al. Automated zebrafish chorion removal and single embryo placement: optimizing throughput of zebrafish developmental toxicity screens. J Lab Autom, 2012; 17:66–74.
27.
KaufmannA, MickoleitM, WeberM, HuiskenJ. Multilayer mounting enables long-term imaging of zebrafish development in a light sheet microscope. Development, 2012; 139:3242–3247.
28.
WehmasLC, AndersC, ChessJ, PunnooseA, PereiraCB, GreenwoodJA, et al. Comparative metal oxide nanoparticle toxicity using embryonic zebrafish. Toxicology Rep, 2015; 2:702–715.
29.
KimKT, TruongL, WehmasL, TanguayRL. Silver nanoparticle toxicity in the embryonic zebrafish is governed by particle dispersion and ionic environment. Nanotechnology, 2013; 24:115101.
30.
KubiatowskiT, JangT, LachyankarMB, SalmonsenR, NabiRR, QuesenberryPJ, et al. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J Neurosurg, 2001; 95:480–488.
31.
ShinguT, YamadaK, HaraN, MoritakeK, OsagoH, TerashimaM, et al. Growth inhibition of human malignant glioma cells induced by the PI3-K-specific inhibitor. J Neurosurg, 2003; 98:154–161.
32.
WelkerAM, JarosBD, PuduvalliVK, ImitolaJ, KaurB, BeattieCE. Standardized orthotopic xenografts in zebrafish reveal glioma cell-line specific characteristics and tumor cell heterogeneity. Dis Model Mech, 2016; 9:199–210.
33.
ZhangB, ShimadaY, KuroyanagiJ, UmemotoN, NishimuraY, TanakaT. Quantitative phenotyping-based in vivo chemical screening in a zebrafish model of leukemia stem cell xenotransplantation. PLoS One, 2014; 9:e85439.
34.
SmithJS, TachibanaI, PasseSM, HuntleyBK, BorellTJ, IturriaN, et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst, 2001; 93:1246–1256.
35.
WangSI, PucJ, LiJ, BruceJN, CairnsP, SidranskyD, et al. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res, 1997; 57:4183–4186.
36.
LiJ, YenC, LiawD, PodsypaninaK, BoseS, WangSI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997; 275:1943–1947.
37.
CantleyLC, NeelBG. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A, 1999; 96:4240–4245.
38.
LeeHC, ParkIC, ParkMJ, AnS, WooSH, JinHO, et al. Sulindac and its metabolites inhibit invasion of glioblastoma cells via down-regulation of Akt/PKB and MMP-2. J Cell Biochem, 2005; 94:597–610.
39.
OstrovskyS, KazimirskyG, GedankenA, BrodieC. Selective cytotoxic effect of ZnO nanoparticles on glioma cells. Nano Res, 2009; 2:882–890.
40.
WahabR, KaushikN, VermaA, MishraA, HwangI, YangY, et al. Fabrication and growth mechanism of ZnO nanostructures and their cytotoxic effect on human brain tumor U87, cervical cancer HeLa, and normal HEK cells. J Biol Inorg Chem, 2011; 16:431–442.
41.
KagaraN, TanakaN, NoguchiS, HiranoT. Zinc and its transporter ZIP10 are involved in invasive behavior of breast cancer cells. Cancer Sci, 2007; 98:692–697.
42.
LiM, ZhangY, LiuZ, BharadwajU, WangH, WangX, et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A, 2007; 104:18636–18641.
43.
BrunNR, LenzM, WehrliB, FentK. Comparative effects of zinc oxide nanoparticles and dissolved zinc on zebrafish embryos and eleuthero-embryos: importance of zinc ions. Sci Total Environ, 2014; 476–477:657–666.
44.
LinY, ChenY, WangY, YangJ, ZhuVF, LiuY, et al. ZIP4 is a novel molecular marker for glioma. Neuro Oncol, 2013; 15:1008–1016.
45.
NakagawaT, KubotaT, KabutoM, SatoK, KawanoH, HayakawaT, et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg, 1994; 81:69–77.
46.
NakanoA, TaniE, MiyazakiK, YamamotoY, FuruyamaJ. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg, 1995; 83:298–307.
